Glaukos Releases Its 2025 Sustainability Report, Highlighting Key Milestones

Published on April 17, 2026
ALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced that it has published its 2025 Sustainability Report. The report highlights the company’s continued commitment and progress on its key corporate sustainability priorities. “I am proud to issue our seventh annual Sustainability Report, which highlights the meaningful progress we continue to make in advancing our core corporate sustainability initiatives that are aligned with our mission and key strategic plans,” said Thomas Burns, Glaukos chairman and CEO.
Continue reading on website
Other news

Optometry Education Conference to bring optometrists, researchers, and educators together

April 17, 2026
The free, online event hosted by the University of Manchester seeks to address a gap in conferences focused on optometry education

Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eyecare Materials Recycled Through ONE by ONE Program

April 17, 2026
VAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) has announced that its ONE by ONE Recycling program, created in collaboration with international recycling leader TerraCycle, has collected and recycled a total of 119,715,074 units, or 724,922 pounds, of used contact lenses, eyecare and lens care materials in the United States. This is the equivalent of about fi